CO10 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Secukinumab at 52 Weeks for the Treatment of Psoriatic Arthritis
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.084
https://www.valueinhealthjournal.com/article/S1098-3015(23)03214-X/fulltext
Title :
CO10 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Secukinumab at 52 Weeks for the Treatment of Psoriatic Arthritis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03214-X&doi=10.1016/j.jval.2023.09.084
First page :
Section Title :
Open access? :
No
Section Order :
10313